RediNews
ETF Investment Portfolio »    IBB Historical Stock Prices »
IBB News Video: Wed, Jun 21, 2017, 1:33 PM — Wednesday's ETF with Unusual Volume: IBB


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
iShares S&P 500 Index Fund is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the Standard & Poor's 500 Index (the Index). The Index measures the performance of the large-capitalization sector of the United States equity market. The Index includes approximately 80% of the market capitalization of all publicly traded the United States equity securities. The component stocks are weighted according to the total float-adjusted market value of their outstanding shares. As of Mar 31 2015, the Fund's total assets were $69,255,887,700 and the Fund's investment portfolio was valued at $69,164,247,657. Self directed investors in iShares Trust - Core S&P 500 Exchange Traded Fund will be interested in keeping up with all iShares Trust - Core S&P 500 Exchange Traded Fund news they can find, both IBB news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on IBB. At RediNews, we simplify this task by presenting both IBB news releases originating from iShares Trust - Core S&P 500 Exchange Traded Fund itself, and IBB news from a variety of media outlets. Visitors can browse this news online and through our IBB RSS news feed.

IBB News

IBB News — Articles, Videos, & Press Releases

IBB, BIIB, REGN, ALXN: ETF Inflow Alert
Friday, September 15, 2017, 10:53 AM — ETF Channel
Oversold Conditions For Regeneron Pharmaceuticals (REGN)
Wednesday, September 13, 2017, 12:00 PM — Dividend Channel
Should You Keep Your Portfolio Healthy with Biotech ETFs?
Tuesday, September 12, 2017, 1:08 PM — Zacks
Analysts Anticipate IBB To Hit $381
Thursday, September 7, 2017, 9:23 AM — ETF Channel
Top ETF Stories of August
Friday, September 1, 2017, 12:06 PM — Zacks
Top Buys by Top Brass: Chief Executive Officer Vounatsos's $380.4K Bet on BIIB
Friday, September 1, 2017, 12:03 PM — Dividend Channel
Biotech ETFs Soar on Gilead-Kite Deal
Tuesday, August 29, 2017, 10:44 AM — Zacks
IBB's Underlying Holdings Imply 23% Gain Potential
Thursday, August 24, 2017, 8:51 AM — ETF Channel
Analysts Anticipate IBB To Hit $378
Thursday, August 10, 2017, 10:55 AM — ETF Channel
3 ETFs to Watch Out for on Biotech Earnings
Monday, July 31, 2017, 10:26 PM — Zacks
The Math Shows IBB Can Go To $371
Thursday, July 27, 2017, 8:37 AM — ETF Channel
Biotech ETF Industry Outlook for Second Half 2017
Monday, July 24, 2017, 4:40 PM — Zacks
Just the Facts, Ma'am: July Strategy Update
Thursday, July 20, 2017, 1:41 PM — Zacks
Biogen Breaks Above 200-Day Moving Average - Bullish for BIIB
Monday, July 17, 2017, 11:23 AM — Market News Video
Analysts See 16% Upside For IBB
Thursday, July 13, 2017, 8:35 AM — ETF Channel
Forget Big Tech, Biotech ETFs are Soaring Higher
Thursday, June 29, 2017, 12:33 PM — Zacks
How Kite Pharma Is Revolutionizing the Fight Against Cancer
Thursday, June 29, 2017, 11:12 AM — Zacks
Analysts Anticipate 14% Upside For The Holdings of IBB
Thursday, June 29, 2017, 9:00 AM — ETF Channel
5 Reasons Why Biotech ETFs are Soaring
Thursday, June 22, 2017, 9:17 AM — Zacks
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data
Wednesday, June 21, 2017, 10:42 AM — Zacks
Fresh Capital to Be Injected into Biotech Stocks: 5 Must-Buys
Wednesday, June 21, 2017, 7:52 AM — Zacks
How The Pieces Add Up: IBB Targets $360
Thursday, June 15, 2017, 8:42 AM — ETF Channel
Analysts Anticipate IBB To Hit $359
Friday, June 2, 2017, 9:01 AM — ETF Channel
Analysts Anticipate IBB To Hit $360
Thursday, May 25, 2017, 9:18 AM — ETF Channel
The Latest Market Trends Every Biopharma Investor Needs to Know
Wednesday, May 17, 2017, 3:37 PM — Zacks
Biogen Enters Oversold Territory (BIIB)
Thursday, May 11, 2017, 12:00 PM — Dividend Channel
Analysts See 23% Gains Ahead For IBB
Thursday, May 11, 2017, 9:20 AM — ETF Channel
Stocks to Watch Ahead of GOP Healthcare Vote
Thursday, May 4, 2017, 10:51 AM — Zacks
Gilead Sciences Posts Mixed Q1 Results: ETFs in Focus
Wednesday, May 3, 2017, 12:58 PM — Zacks
Regeneron Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for REGN
Friday, April 28, 2017, 12:07 PM — Market News Video
Analysts Anticipate IBB Will Reach $357
Thursday, April 27, 2017, 9:16 AM — ETF Channel
iShares Nasdaq Biotechnology ETF Experiences Big Inflow
Thursday, April 20, 2017, 1:36 PM — ETF Channel
The Implied Analyst 12-Month Target For IBB
Wednesday, April 19, 2017, 8:18 AM — ETF Channel
Sum Up The Parts: IBB Could Be Worth $356
Tuesday, April 11, 2017, 8:29 AM — ETF Channel
Are Q1 ETF Toppers Healthy Enough for Further Run in Q2?
Friday, April 7, 2017, 9:03 AM — Zacks
REGN Makes Notable Cross Below Critical Moving Average
Tuesday, April 4, 2017, 11:30 AM — Market News Video
Sum Up The Pieces: IBB Could Be Worth $357
Monday, April 3, 2017, 8:22 AM — ETF Channel
Add Up The Pieces: IBB Could Be Worth $353
Friday, March 24, 2017, 10:12 AM — ETF Channel
Biotech Bull Making a Comeback
Tuesday, March 21, 2017, 5:00 AM — Zacks
Trump, Biogen and Amgen Hammer Healthcare ETFs
Monday, March 20, 2017, 8:22 AM — Zacks
BIIB Crosses Below Key Moving Average Level
Thursday, March 16, 2017, 11:26 AM — Market News Video
Noteworthy ETF Outflows: IBB, BIIB, REGN, INCY
Thursday, March 16, 2017, 10:59 AM — ETF Channel
ETF Flows Report for 03/16/2017
Thursday, March 16, 2017, 10:46 AM — ETF Channel
Look Under The Hood: IBB Has 17% Upside
Thursday, March 16, 2017, 9:18 AM — ETF Channel
Time to Buy Biotech ETFs?
Monday, March 13, 2017, 3:46 PM — Zacks
REGN Crosses Above Key Moving Average Level
Thursday, March 9, 2017, 11:37 AM — Market News Video
Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs
Wednesday, March 8, 2017, 9:07 AM — Zacks
Healthcare ETFs in Focus on Obamacare Replacement Plan
Tuesday, March 7, 2017, 8:58 AM — Zacks
Top Buys by Directors: Vounatsos's $380.4K Bet on BIIB
Thursday, March 2, 2017, 1:09 PM — Dividend Channel
Trump's Immigration Plans an Overhang on Biotech ETFs?
Thursday, March 2, 2017, 1:00 PM — Zacks
Top Buys by Top Brass: Chief Executive Officer Vounatsos's $380.4K Bet on BIIB
Thursday, March 2, 2017, 10:04 AM — Dividend Channel
IBB, REGN, ILMN, ALXN: Large Outflows Detected at ETF
Monday, February 27, 2017, 10:56 AM — ETF Channel
ETF Industry to Get a Product on Marijuana?
Thursday, February 23, 2017, 10:45 AM — Zacks
Sum Up The Parts: IBB Could Be Worth $355
Thursday, February 23, 2017, 9:53 AM — ETF Channel
Bullish Two Hundred Day Moving Average Cross - REGN
Wednesday, February 15, 2017, 4:26 PM — Market News Video
IBB, GILD, CELG, ALXN: ETF Outflow Alert
Wednesday, February 15, 2017, 10:48 AM — ETF Channel
The Implied Analyst 12-Month Target For IBB
Thursday, February 9, 2017, 8:32 AM — ETF Channel
Healthcare Stocks: The Buying Opportunity of the Year?
Tuesday, February 7, 2017, 6:47 PM — Zacks
Analysts Anticipate IBB Will Reach $350
Wednesday, February 1, 2017, 8:55 AM — ETF Channel
Biotech Stocks Gain on Latest Trump Drug Price Statements
Tuesday, January 31, 2017, 12:08 PM — Zacks
What Lies Ahead for Biotech ETFs in Trump Era?
Friday, January 27, 2017, 3:30 PM — Zacks
Analysts Expect 29% Upside For IBB
Tuesday, January 24, 2017, 9:17 AM — ETF Channel
4 Top Biotech Mutual Funds for 2017
Wednesday, January 18, 2017, 9:03 AM — Zacks
Trump Attacks Biotech & Pharma: ETFs Bleed
Thursday, January 12, 2017, 9:08 AM — Zacks
We Did The Math IBB Can Go To $352
Thursday, January 12, 2017, 8:41 AM — ETF Channel
Notable ETF Inflow Detected - IBB, REGN, ALXN, INCY
Tuesday, January 10, 2017, 10:51 AM — ETF Channel
Bullish Two Hundred Day Moving Average Cross - IBB
Wednesday, January 4, 2017, 11:25 AM — ETF Channel
Ten Predictions for the ETF Industry in 2017
Tuesday, January 3, 2017, 6:12 PM — Zacks
Biogen Shares Cross Below 200 DMA
Friday, December 30, 2016, 4:39 PM — Market News Video
Analysts Forecast 31% Gains Ahead For The Holdings of IBB
Thursday, December 29, 2016, 10:20 AM — ETF Channel
Analysts See 30% Upside For The Holdings of IBB
Wednesday, December 21, 2016, 9:34 AM — ETF Channel
ETF Flows Report for 12/20/2016
Tuesday, December 20, 2016, 10:46 AM — ETF Channel
Noteworthy ETF Inflows: IBB, REGN, MYL, ALXN
Monday, December 19, 2016, 11:07 AM — ETF Channel
ETF Flows Report for 12/19/2016
Monday, December 19, 2016, 10:45 AM — ETF Channel
Look Under The Hood: IBB Has 30% Upside
Tuesday, December 13, 2016, 9:05 AM — ETF Channel
REGN Crosses Above Key Moving Average Level
Monday, December 12, 2016, 11:35 AM — Market News Video
5 Stocks That Got Run Over By the Trump Train
Friday, December 9, 2016, 3:05 PM — Zacks
5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices
Thursday, December 8, 2016, 3:19 PM — Zacks
Biotech & Pharma ETFs to Suffer in 2017 Too?
Thursday, December 8, 2016, 2:00 PM — Zacks
Stock Market Roundup Dec. 7: Stocks Gain Despite Biotech Sell-Off
Wednesday, December 7, 2016, 4:10 PM — Zacks
Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower
Wednesday, December 7, 2016, 12:40 PM — Zacks
Biogen Breaks Below 200-Day Moving Average - Notable for BIIB
Wednesday, December 7, 2016, 11:30 AM — Market News Video
iShares Nasdaq Biotechnology (IBB) Shares Cross Below 200 DMA
Thursday, December 1, 2016, 10:58 AM — ETF Channel
5 Top-Ranked Sector ETFs Thankful to Trump
Wednesday, November 23, 2016, 11:39 AM — Zacks
The Math Shows IBB Can Go To $356
Thursday, November 17, 2016, 9:11 AM — ETF Channel
Is Immunotherapy the Next Hot Industry for Biotech Stock Investors?
Wednesday, November 16, 2016, 4:22 PM — Zacks
IBB, REGN, ALXN, VRTX: ETF Inflow Alert
Tuesday, November 15, 2016, 10:50 AM — ETF Channel
The Trump Effect: 8 Must-See ETF Charts
Monday, November 14, 2016, 12:49 PM — Zacks
4 Best Healthcare Mutual Funds to Profit from Trump Win
Friday, November 11, 2016, 9:59 AM — Zacks
5 Top Biotech Stocks to Buy on Trump Victory
Thursday, November 10, 2016, 6:48 AM — Zacks
Regeneron Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for REGN
Wednesday, November 9, 2016, 1:27 PM — Market News Video
iShares Nasdaq Biotechnology (IBB) Shares Cross Above 200 DMA
Wednesday, November 9, 2016, 11:05 AM — ETF Channel
Biotech ETFs Slumping on Q3 Results
Tuesday, November 8, 2016, 2:26 PM — Zacks
Surprising Analyst 12-Month Target For IBB
Monday, November 7, 2016, 9:26 AM — ETF Channel
Healthcare ETFs in the Spotlight as Election Approaches
Monday, November 7, 2016, 9:02 AM — Zacks
BIIB Crosses Below Key Moving Average Level
Thursday, November 3, 2016, 12:40 PM — Market News Video
BIIB Crosses Below Key Moving Average Level
Thursday, November 3, 2016, 12:39 PM — Market News Video
iShares Nasdaq Biotechnology Getting Very Oversold
Wednesday, November 2, 2016, 10:58 AM — ETF Channel
Regeneron Pharmaceuticals Becomes Oversold (REGN)
Monday, October 31, 2016, 12:04 PM — Dividend Channel
Sum Up The Pieces: IBB Could Be Worth $360
Friday, October 28, 2016, 9:37 AM — ETF Channel
iShares Nasdaq Biotechnology ETF Experiences Big Outflow
Monday, October 24, 2016, 11:07 AM — ETF Channel
How The Pieces Add Up: IBB Headed For $366
Thursday, October 20, 2016, 9:38 AM — ETF Channel
ETFs to Play as Biotech Juggles Election & Earnings
Monday, October 17, 2016, 8:10 AM — Zacks
Prepare for a Clinton Presidency with These Stocks & ETFs
Tuesday, October 11, 2016, 12:55 PM — Zacks
Nasdaq and Eurozone: 2 ETFs to Watch on Outsized Volume
Friday, October 7, 2016, 8:52 AM — Zacks
Surprising Analyst 12-Month Target For IBB
Monday, October 3, 2016, 9:36 AM — ETF Channel
Clinton Apparently Won First Debate: ETFs in Focus
Tuesday, September 27, 2016, 9:03 AM — Zacks
Prepare for a Trump Presidency With These Stocks & ETFs
Friday, September 23, 2016, 12:45 PM — Zacks
Regeneron Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for REGN
Friday, September 23, 2016, 11:41 AM — Market News Video
ETFs in Focus on the Nasdaq Rally
Friday, September 23, 2016, 9:05 AM — Zacks
Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
Wednesday, September 21, 2016, 9:23 AM — Zacks
Inside the Recent Surge in Biotech ETFs
Wednesday, September 14, 2016, 12:19 PM — Zacks
IBB's Underlying Holdings Could Mean 27% Gain Potential
Tuesday, September 13, 2016, 7:58 AM — ETF Channel
We Did The Math IBB Can Go To $366
Friday, September 2, 2016, 9:29 AM — ETF Channel
Biotech ETF Industry Outlook
Wednesday, August 31, 2016, 1:39 PM — Zacks
Biotech ETFs in Focus After Mylan's EpiPen Controversy
Friday, August 26, 2016, 8:27 AM — Zacks
Sum Up The Parts: IBB Could Be Worth $366
Thursday, August 25, 2016, 8:04 AM — ETF Channel
Analysts See 28% Gains Ahead For The Holdings of IBB
Thursday, August 11, 2016, 7:50 AM — ETF Channel
ETFs to Watch as Nasdaq Hits All-Time High
Tuesday, August 9, 2016, 12:29 PM — Zacks
Clinton vs. Trump: Best Stocks & ETFs to Bet On
Wednesday, August 3, 2016, 11:22 AM — Zacks
Analysts Forecast 28% Upside For The Holdings of IBB
Thursday, July 28, 2016, 7:31 AM — ETF Channel
IBB Crosses Above Key Moving Average Level
Wednesday, July 27, 2016, 4:11 PM — ETF Channel
Here's How Presidents and Elections Affect the Stock Market
Thursday, July 21, 2016, 2:19 PM — Zacks
BIIB Makes Bullish Cross Above Critical Moving Average
Thursday, July 21, 2016, 11:39 AM — Market News Video
Add Up The Pieces: IBB Could Be Worth $365
Wednesday, July 20, 2016, 7:53 AM — ETF Channel
Analysts Anticipate IBB To Hit $363
Tuesday, July 12, 2016, 8:09 AM — ETF Channel
Top and Flop ETFs of 1H
Thursday, June 30, 2016, 9:28 AM — Zacks
Analysts Anticipate IBB Will Reach $359
Friday, June 24, 2016, 7:21 AM — ETF Channel
Analysts Predict 41% Upside For IBB
Thursday, June 16, 2016, 8:25 AM — ETF Channel
Biogen Becomes Oversold (BIIB)
Monday, June 13, 2016, 4:30 PM — Dividend Channel
4 Stocks That Crushed the Biotechnology ETF (IBB) This Week
Friday, June 10, 2016, 11:15 AM — Zacks
Analysts Forecast 33% Upside For IBB
Wednesday, June 8, 2016, 7:45 AM — ETF Channel
Analysts Predict 34% Gains Ahead For IBB
Tuesday, May 31, 2016, 7:57 AM — ETF Channel
Bullish Two Hundred Day Moving Average Cross - BIIB
Thursday, May 26, 2016, 11:30 AM — Market News Video
Analysts Anticipate IBB To Hit $364
Monday, May 23, 2016, 7:03 AM — ETF Channel
Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
Tuesday, May 17, 2016, 9:40 AM — Zacks
What Lies Ahead for Biotech ETFs?
Friday, May 13, 2016, 2:48 PM — Zacks
The Math Shows IBB Can Go To $362
Friday, May 13, 2016, 7:53 AM — ETF Channel
We Did The Math IBB Can Go To $383
Thursday, May 5, 2016, 8:17 AM — ETF Channel
Biotech ETFs Sink on Mixed Q1 Results
Monday, May 2, 2016, 1:22 PM — Zacks
IBB, BIIB, CELG, REGN: ETF Inflow Alert
Friday, April 29, 2016, 11:01 AM — ETF Channel
IBB, REGN, ILMN, ALXN: ETF Outflow Alert
Thursday, April 21, 2016, 11:11 AM — ETF Channel
How The Parts Add Up: IBB Targets $388
Thursday, April 21, 2016, 7:55 AM — ETF Channel
IBB, REGN, ILMN, MYL: Large Inflows Detected at ETF
Monday, April 11, 2016, 10:55 AM — ETF Channel
The Implied Analyst 12-Month Target For IBB
Thursday, April 7, 2016, 8:06 AM — ETF Channel
Amgen Breaks Above 200-Day Moving Average - Bullish for AMGN
Monday, April 4, 2016, 11:51 AM — Dividend Channel
Look Under The Hood: IBB Has 56% Upside
Thursday, March 24, 2016, 7:52 AM — ETF Channel
IBB, REGN, ILMN, ALXN: Large Inflows Detected at ETF
Tuesday, March 22, 2016, 11:28 AM — ETF Channel
Analysts Predict 40% Upside For IBB
Tuesday, March 15, 2016, 7:56 AM — ETF Channel
We Did The Math IBB Can Go To $369
Monday, March 7, 2016, 7:32 AM — ETF Channel
5 Revenant Sectors Echo Leo's Oscar-Winning Performance
Friday, March 4, 2016, 2:30 PM — Zacks
IBB's Holdings Imply 45% Gain Potential
Tuesday, February 23, 2016, 8:01 AM — ETF Channel
Generic ETF in Focus as Biotech Lose Charm
Wednesday, February 17, 2016, 12:59 PM — Zacks
IBB's Underlying Holdings Imply 66% Gain Potential
Thursday, February 11, 2016, 7:52 AM — ETF Channel
Biotech ETFs Slide as Stocks Report Mixed Q4 Results
Tuesday, February 9, 2016, 12:48 PM — Zacks
Add Up The Parts: IBB Could Be Worth $424
Wednesday, February 3, 2016, 2:19 PM — ETF Channel
Biotech ETFs Hit 52-Week Lows: Time to Buy?
Monday, February 1, 2016, 8:30 AM — Zacks
Biotech ETF (IBB) Hits New 52-Week Low
Friday, January 29, 2016, 7:59 AM — Zacks
iShares Nasdaq Biotechnology Getting Very Oversold
Tuesday, January 19, 2016, 3:52 PM — ETF Channel
Is The Time Ripe for Ex-Health Care S&P 500 ETF?
Wednesday, January 13, 2016, 12:05 PM — Zacks
Biotech On the Edge? Try Better-Performing Health Care ETFs
Tuesday, January 12, 2016, 12:02 PM — Zacks
Regeneron Pharmaceuticals is Now Oversold (REGN)
Friday, January 8, 2016, 5:14 PM — Dividend Channel
What Lies Ahead for Biotech ETFs in 2016?
Friday, January 8, 2016, 4:55 PM — Zacks
Nasdaq Outperforms: 3 ETFs in Focus
Wednesday, December 30, 2015, 12:45 PM — Zacks
IBB, AMGN, REGN, BIIB: Large Outflows Detected at ETF
Friday, December 11, 2015, 10:57 AM — ETF Channel
Noteworthy ETF Outflows: IBB, REGN, BIIB, ALXN
Thursday, December 3, 2015, 11:28 AM — ETF Channel
Interesting IBB Put And Call Options For January 2018
Monday, November 16, 2015, 11:50 AM — Stock Options Channel
IBB, REGN, AMGN, CELG: ETF Outflow Alert
Friday, November 13, 2015, 11:00 AM — ETF Channel
Biotech Sees Better-than-Expected Earnings: ETFs in Focus
Friday, November 6, 2015, 10:22 AM — Zacks
IBB, CELG, REGN, AMGN: Large Inflows Detected at ETF
Thursday, November 5, 2015, 11:22 AM — ETF Channel
October ETF Asset-Flow Roundup
Monday, November 2, 2015, 11:25 AM — Zacks
Noteworthy ETF Inflows: IBB, AMGN, CELG, REGN
Thursday, October 29, 2015, 11:02 AM — ETF Channel
Interesting IBB Put And Call Options For June 2016
Thursday, October 22, 2015, 10:55 AM — Stock Options Channel
Breakthrough Biotech ETF on Cancer Treatment
Monday, October 19, 2015, 11:54 AM — Zacks
Bull of the Day: Repligen (RGEN)
Monday, October 19, 2015, 7:01 AM — Zacks
Make Big Gains From This Market Overreaction
Friday, October 9, 2015, 12:30 PM — StreetAuthority
7 Huge Mistakes Every ETF Investor Needs to Avoid
Friday, October 9, 2015, 8:45 AM — Zacks
Biotech ETFs Looking Attractive After Sell-Off
Thursday, October 1, 2015, 6:55 AM — Zacks
Top ETF Stories of September
Wednesday, September 30, 2015, 11:34 AM — Zacks
How to Short Biotechnology Stocks with ETFs
Tuesday, September 29, 2015, 8:17 AM — Zacks
Regeneron Pharmaceuticals Becomes Oversold (REGN)
Monday, September 28, 2015, 1:01 PM — Dividend Channel
Regeneron Pharmaceuticals (REGN) Shares Cross Below 200 DMA
Monday, September 28, 2015, 11:41 AM — Market News Video
Ill at Ease with Biotech? Prescribing #1 Healthcare ETFs
Monday, September 28, 2015, 10:16 AM — Zacks
IBB is categorized under the Financials sector; below are links to news for some other companies in the same sector:

SMH News
XLV News
IYG News
C News
BAC News
VEU News
XLP News
VUG News
DEM News
VOO News

RSS news feeds from RediNews are an ideal complement to other financial content on your market-focused website like stock quotes and charts. our news gives your users what they want — to see what is being published about the stocks they own, and what the companies themselves are publishing. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): . These feeds are made available to you free if charge. We also offer news by broad sector, and a feed of all recent stock news.

IBB News | www.RediNews.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.